Posted by Michael Wonder on 13 Sep 2021
EMA publishes agenda for 13-16 September CHMP meeting
13 September 2021 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Artesunate
- Zanubrutinib
- Adalimumab
- Pegcetacoplan
- Ripretinib
- Tanezumab
- Lasmiditan
- Rivaroxaban
- Sugammadex
- Glucarpidase
- Diroximel fumarate
Read CHMP agenda
Posted by:
Michael Wonder